Recommend one FDA-approved drug (Verapamil), one off-label drug (Lamotrigine), and one nonpharmacological intervention (Interpersonal therapy) for treating Bipolarism in pregnant women.

Recommend one FDA-approved drug (Verapamil), one off-label drug (Lamotrigine), and one nonpharmacological intervention (Interpersonal therapy) for treating Bipolarism in pregnant women.
Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
Explain whether clinical practice guidelines exist for this disorder, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a nonpharmacological intervention for the disorder.